Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
As of today, Moderna(MRNA) shares are valued at $68.30. The company's market cap stands at 27.09B, with a P/E ratio of -8.38.
As of 2026-07-12, Moderna(MRNA) stock has fluctuated between $67.31 and $78.25. The current price stands at $68.30, placing the stock +1.5% above today's low and -12.7% off the high.
The Moderna(MRNA)'s current trading volume is 9.18M, compared to an average daily volume of 10.39M.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $85.60 at its peak.
During the past year, Moderna(MRNA) stock moved between $22.28 at its lowest and $85.60 at its peak.
MRNA News
The S&P 500 (SPX) closed higher on Friday on signs of easing U.S.-Iran tensions. TipRanks has entered a new arena in the investing world, powering the index of...
...
Shares in Moderna (MRNA) tumbled by 12% on Friday afternoon after JPMorgan (JPM) reaffirmed its Sell rating on the U.S. pharma and biotech company. The banking...
Analyst ratings
69%
of 26 ratingsMore MRNA News
Moderna (MRNA) is down -10.7%, or -$8.17 to $68.39. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investmen...
Moderna (NasdaqGS:MRNA) has settled a long running patent dispute with Arbutus Biopharma and Genevant Sciences related to COVID-19 vaccine technology. The agre...
Moderna (MRNA) announced the appointment of Michael McDonnell to its Board of Directors, effective July 8, 2026. He will also join the board's audit committee....
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
Key Points Moderna’s first big success was its coronavirus vaccine -- that product brought in $18 billion in revenue at its peak. The biotech recently submitt...
Key Points Each of these biotech players has reached an important turning point. Recent drug approvals could supercharge the performance of one in particular....
Moderna (MRNA) closed at $81.76 in the latest trading session, marking a +2.51% move from the prior day. This move outpaced the S&P 500's daily gain of 0.72%. M...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.